Edwards Lifesciences (EW) is a publicly traded Healthcare sector company. As of August 26, 2026, EW trades at $90.65 with a market cap of $52.16B and a P/E ratio of 52.38. EW moved +0.41% today. Year to date, EW is +6.49%; over the trailing twelve months it is +12.38%. Its 52-week range spans $65.94 to $96.29. Analyst consensus is strong buy with an average price target of $102.88. Rallies surfaces EW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
18 analysts cover EW: 0 strong buy, 15 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $102.88.
| Metric | Value |
|---|---|
| Price | $90.65 |
| Market Cap | $52.16B |
| P/E Ratio | 52.38 |
| EPS | $1.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $96.29 |
| 52-Week Low | $65.94 |
| Volume | 1.55M |
| Avg Volume | 0 |
| Revenue (TTM) | $6.51B |
| Net Income | $1.00B |
| Gross Margin | 77.84% |
18 analysts cover EW: 0 strong buy, 15 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.88.